[Late-age onset systemic sclerosis]

Area of Science:

• Rheumatology
• Internal Medicine
• Vascular Biology

Background:

• Systemic sclerosis (SSc) is a multi-organ connective tissue disease.
• SSc involves blood vessel dysfunction, inflammation, and fibrosis.
• Onset typically occurs between 30-50 years, but can occur in younger or older individuals.

Purpose of the Study:

• To investigate the distinct characteristics and outcomes of late-onset systemic sclerosis.
• To compare the clinical presentation and prognosis of SSc in older versus younger patients.

Main Methods:

• Retrospective analysis of patient data.
• Comparison of clinical features and outcomes based on age of onset.
• Statistical analysis of mortality rates and associated risk factors.

Main Results:

• Late-onset SSc (>60 years) is associated with limited cutaneous involvement, pulmonary hypertension, and primary cardiac issues.
• Anti-centromere antibodies are more prevalent in late-onset SSc.
• Older SSc patients face poorer prognosis, higher mortality, and increased neoplasm risk.

Conclusions:

• Age significantly impacts the clinical course and prognosis of systemic sclerosis.
• Late-onset SSc requires tailored diagnostic and management strategies.
• Increased vigilance for neoplasms is crucial in elderly SSc patients.